Literature DB >> 17936463

SULT1C3, an orphan sequence of the human genome, encodes an enzyme activating various promutagens.

Walter Meinl1, Claudia Donath, Heiko Schneider, Yasmin Sommer, Hansruedi Glatt.   

Abstract

The human genome contains a sequence that is homologous to genes encoding soluble sulphotransferases (SULTs) based on the nucleotide sequence and possible intron/exon splice sites. The putative coding sequence (termed SULT1C3) was synthesized and integrated into a bacterial expression vector. We used the cDNA-expressed protein for raising an antiserum and studying enzyme activities. No activity was detected with 4-nitrophenol and 1-naphthol, known substrates of all other members of the human SULT1 subfamily. The activity was also negligible with paracetamol, ethanol, 5-hydroxymethylfurfural, 2-hydroxymethylpyrene, 2-(alpha-hydroxy)ethylpyrene, and corticosterone, compounds for which we have developed sensitive enzyme assays with direct determination of the product by HPLC-UV, HPLC-fluorescence or HPLC-MS/MS. Since diverse sulpho conjugates are chemically reactive - often short-lived and mutagenic - we expressed SULT1C3 in Ames'Salmonella typhimurium strains TA1538 and TA100, as we had done with many other SULTs previously. The expression level of SULT1C3 protein amounted to 2% of the total cytosolic proteins, which is in the middle range of other SULTs expressed in this model. Using recombinant bacterial tester strains in mutagenicity assays, we observed SULT1C3-mediated activation of several large benzylic alcohols derived from alkylated polycyclic hydrocarbons: 1-hydroxymethylpyrene, both enantiomers of 1-(alpha-hydroxy)ethylpyrene, 6-hydroxymethylbenzo[a]pyrene and 6-hydroxymethylanthanthrene. 1'-Hydroxysafrole was the smallest molecule activated by SULT1C3 up to date. Our study demonstrates that SULT1C3 has sulphotransferase activity and that it prefers relatively large substrates. The substrates detected were activated to mutagens, which cannot be the regular function of the enzyme. The physiological substrates remain to be identified. Probably, they are relatively large, endogenous or common exogenous, molecules.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936463     DOI: 10.1016/j.fct.2007.08.040

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Expression of the orphan cytosolic sulfotransferase SULT1C3 in human intestine: characterization of the transcript variant and implications for function.

Authors:  Zofia Duniec-Dmuchowski; Elizabeth A Rondini; Zachary E Tibbs; Charles N Falany; Melissa Runge-Morris; Thomas A Kocarek
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

3.  Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells.

Authors:  Elizabeth A Rondini; Hailin Fang; Melissa Runge-Morris; Thomas A Kocarek
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

4.  Transcriptional Regulation of Human Cytosolic Sulfotransferase 1C3 by Peroxisome Proliferator-Activated Receptor γ in LS180 Human Colorectal Adenocarcinoma Cells.

Authors:  Sarah Dubaisi; Hailin Fang; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Mol Pharmacol       Date:  2016-08-26       Impact factor: 4.436

5.  Human Cytosolic Sulphotransferase SULT1C3: genomic analysis and functional characterization of splice variant SULT1C3a and SULT1C3d.

Authors:  Katsuhisa Kurogi; Takehiko Shimohira; Haruna Kouriki-Nagatomo; Guisheng Zhang; Ethan R Miller; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  J Biochem       Date:  2017-12-01       Impact factor: 3.387

Review 6.  SULT genetic polymorphisms: physiological, pharmacological and clinical implications.

Authors:  Katsuhisa Kurogi; Mohammed I Rasool; Fatemah A Alherz; Amal A El Daibani; Ahsan F Bairam; Maryam S Abunnaja; Shin Yasuda; Lauren J Wilson; Ying Hui; Ming-Cheh Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-06-30       Impact factor: 4.936

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.